Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Siripen Kanchanasuwan, Narongdet Kositpantawong, Kamonnut Singkhamanan, Thanaporn Hortiwakul, Boonsri Charoenmak, Nwabor Ozioma F, Yohei Doi & Sarunyou Chusri. (2021) Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii. Infection and Drug Resistance 14, pages 1255-1264.
Read now
Read now
Jiun-Ling Wang, Chih-Feng Kuo, Che-Ming Yeh, Jung-Ren Chen, Ming-Fang Cheng & Chih-Hsin Hung. (2018) Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection. Infection and Drug Resistance 11, pages 2301-2310.
Read now
Read now
Karthikeyan Ramalingam & Valerie A. Lee. (2018) Antibiofilm activity of an EDTA-containing nanoemulsion on multidrug-resistant Acinetobacter baumannii. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 737-743.
Read now
Read now
Himen Salimizand, Shaho Menbari, Rashid Ramazanzadeh, Masomeh Khonsha & Mohammad Saleh Vahedi. (2016) DNA fingerprinting and antimicrobial susceptibility pattern of clinical and environmental Acinetobacter baumannii isolates: a multicentre study. Journal of Chemotherapy 28:4, pages 277-283.
Read now
Read now
Younes Smani, María Eugenia Pachón-Ibáñez & Jerónimo Pachón. (2016) New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii. Expert Opinion on Pharmacotherapy 17:9, pages 1207-1214.
Read now
Read now
Jaime A Labarca, Mauro José Costa Salles, Carlos Seas & Manuel Guzmán-Blanco. (2016) Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Critical Reviews in Microbiology 42:2, pages 276-292.
Read now
Read now
María Eugenia Pachón-Ibáñez, Younes Smani & Jerónimo Pachón. (2016) Use of adjuvants in the treatment of Acinetobacter baumannii. Expert Review of Anti-infective Therapy 14:2, pages 153-155.
Read now
Read now
Alexandre P Zavascki, Jurgen B Bulitta & Cornelia B Landersdorfer. (2013) Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert Review of Anti-infective Therapy 11:12, pages 1333-1353.
Read now
Read now
Rafael López-Rojas, Younes Smani & Jerónimo Pachón. (2013) Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors. Expert Review of Anti-infective Therapy 11:3, pages 231-233.
Read now
Read now
Articles from other publishers (58)
Menglu Wang, Yu Ning, Xin Jiao, Jiayi Liu & Jinjuan Qiao. (2023) Bacteriophages and their derived enzymes as promising alternatives for the treatment of Acinetobacter baumannii infections. Archives of Virology 168:12.
Crossref
Crossref
Soraya Herrera-Espejo, Ester Del Barrio-Tofiño, Tania Cebrero-Cangueiro, Carla López-Causapé, Rocío Álvarez-Marín, José Miguel Cisneros, Jerónimo Pachón, Antonio Oliver & María Eugenia Pachón-Ibáñez. (2022) Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis. Antibiotics 11:9, pages 1212.
Crossref
Crossref
Massimiliano Lucidi, Radu Hristu, Lorenzo Nichele, George A. Stanciu, Paolo Visca, Cosmin K. Banica, Gabriella Cincotti & Stefan G. Stanciu. (2021)
Characterization of
Acinetobacter baumannii
Filamentous Cells by Re-Scan Confocal Microscopy and Complementary Fluorometric Approaches
. IEEE Journal of Selected Topics in Quantum Electronics 27:5, pages 1-7.
Crossref
Crossref
J. Dawan, J.‐C. Kim & J. Ahn. (2021)
Insights into collateral susceptibility and collateral resistance in
Acinetobacter baumannii
during antimicrobial adaptation
. Letters in Applied Microbiology 73:2, pages 168-175.
Crossref
Crossref
T Cebrero-Cangueiro, P Nordmann, M Carretero-Ledesma, J Pachón & M E Pachón-Ibáñez. (2021)
Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing
Acinetobacter baumannii
. Journal of Antimicrobial Chemotherapy 76:3, pages 680-683.
Crossref
Crossref
Weerayuth Saelim, Dhitiwat Changpradub, Sudaluck Thunyaharn, Piraporn Juntanawiwat, Parnrada Nulsopapon & Wichai Santimaleeworagun. (2021)
Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant
Acinetobacter baumannii
: Improved Efficacy or Decreased Risk of Nephrotoxicity?
. Infection & Chemotherapy 53:1, pages 128.
Crossref
Crossref
I-Ming Lee, I-Fan Tu, Feng-Ling Yang & Shih-Hsiung Wu. (2020) Bacteriophage Tail-Spike Proteins Enable Detection of Pseudaminic-Acid-Coated Pathogenic Bacteria and Guide the Development of Antiglycan Antibodies with Cross-Species Antibacterial Activity. Journal of the American Chemical Society 142:46, pages 19446-19450.
Crossref
Crossref
Benjamin A Pontefract, Hong T Ho, Alexandria Crain, Madan K Kharel & S Eric Nybo. (2020) Drugs for Gram-Negative Bugs From 2010–2019: A Decade in Review. Open Forum Infectious Diseases 7:7.
Crossref
Crossref
Y. Wang, X. Li, D. Wang, S. Sun & C. Lu. (2019)
In vitro
interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem‐resistant
Acinetobacter baumannii
. Letters in Applied Microbiology 70:3, pages 189-195.
Crossref
Crossref
Viviana Cafiso, Stefano Stracquadanio, Flavia Lo Verde, Veronica Dovere, Alessandra Zega, Giuseppe Pigola, Jesús Aranda & Stefania Stefani. (2020) COLRAcinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets. Frontiers in Microbiology 10.
Crossref
Crossref
Amin Talebi Bezmin Abadi, Albert A. Rizvanov, Thomas Haertlé & Nataliya L. Blatt. (2019) World Health Organization Report: Current Crisis of Antibiotic Resistance. BioNanoScience 9:4, pages 778-788.
Crossref
Crossref
William Gustavo Lima, Geisa Cristina Silva Alves, Cristina Sanches, Simone Odília Antunes Fernandes & Magna Cristina de Paiva. (2019) Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis. Burns 45:7, pages 1495-1508.
Crossref
Crossref
Julio César García, Henry Robayo Amortegui & Adriana Carrasco Márquez. (2019) Multirresistencia de Acinetobacter baumannii: revisión narrativa. Acta Colombiana de Cuidado Intensivo 19:4, pages 219-226.
Crossref
Crossref
Meera Surendran-Nair, Patrick Lau, Yanyan Liu & K. Venkitanarayanan. (2019) Efficacy of selenium in controlling Acinetobacter baumannii associated wound infections. Wound Medicine 26:1, pages 100165.
Crossref
Crossref
Alessandra Oliva, Stefania Garzoli, Massimiliano De Angelis, Carolina Marzuillo, Vincenzo Vullo, Claudio Mastroianni & Rino Ragno. (2019) In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii. Molecules 24:5, pages 886.
Crossref
Crossref
A. Jahangiri, P. Owlia, I. Rasooli, J. Salimian, E. Derakhshanifar, A. Naghipour Erami, E. Darzi Eslam & S. Darvish Alipour Astaneh. (2019)
Specific egg yolk antibodies (IgY) confer protection against
Acinetobacter baumannii
in a murine pneumonia model
. Journal of Applied Microbiology 126:2, pages 624-632.
Crossref
Crossref
Viviana Cafiso, Stefano Stracquadanio, Flavia Lo Verde, Giacoma Gabriele, Maria Lina Mezzatesta, Carla Caio, Giuseppe Pigola, Alfredo Ferro & Stefania Stefani. (2019) Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy. Frontiers in Microbiology 9.
Crossref
Crossref
Jerry Altshuler, Samuel L. Aitken, Melanie Maslow, John Papadopoulos & Amar Safdar. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
855
901
.
Kenneth V. I. Rolston & Amar Safdar. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
461
472
.
Rungong Yang, Honghong Zhang, Xiaoxia Li, Ling Ye, Meiliang Gong, Jinghui Yang, Jihong Yu & Jie Bai. (2018)
A multiplex loop-mediated isothermal amplification assay for rapid screening of
Acinetobacter baumannii
and D carbapenemase
OXA-23
gene
. Bioscience Reports 38:5.
Crossref
Crossref
Rafael Ayerbe-Algaba, María Luisa Gil-Marqués, Manuel Enrique Jiménez-Mejías, Viviana Sánchez-Encinales, Raquel Parra-Millán, María Eugenia Pachón-Ibáñez, Jerónimo Pachón & Younes Smani. (2018) Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
I-Ming Lee, Feng-Ling Yang, Te-Li Chen, Kuo-Shiang Liao, Chien-Tai Ren, Nien-Tsung Lin, Yu-Pei Chang, Chung-Yi Wu & Shih-Hsiung Wu. (2018)
Pseudaminic Acid on Exopolysaccharide of
Acinetobacter baumannii
Plays a Critical Role in Phage-Assisted Preparation of Glycoconjugate Vaccine with High Antigenicity
. Journal of the American Chemical Society 140:28, pages 8639-8643.
Crossref
Crossref
Chunhong Peng, Jin Han, Xianwei Ye & Xiangyan Zhang. (2018) IL-33 Treatment Attenuates the Systemic Inflammation Reaction in Acinetobacter baumannii Pneumonia by Suppressing TLR4/NF-κB Signaling. Inflammation 41:3, pages 870-877.
Crossref
Crossref
Abolfazl Jahangiri, Iraj Rasooli, Parviz Owlia, Abbas Ali Imani Fooladi & Jafar Salimian. (2018) An integrative in silico approach to the structure of Omp33-36 in Acinetobacter baumannii. Computational Biology and Chemistry 72, pages 77-86.
Crossref
Crossref
Shakti Laishram, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam & Balaji Veeraraghavan. (2017) An Update on Technical, Interpretative and Clinical Relevance of Antimicrobial Synergy Testing Methodologies. Indian Journal of Medical Microbiology 35:4, pages 445-468.
Crossref
Crossref
Hui Li, Hua Zhou, Xi Li, Jianfeng Wang, Ying Fu, Yan Jiang & Yunsong Yu. (2017) The Evaluation of Four In Vitro Susceptibility Testing Methods for Colistin on Carbapenenm-Resistant Acinetobacter baumannii. Jundishapur Journal of Microbiology 10:9.
Crossref
Crossref
I-Ming Lee, I-Fan Tu, Feng-Ling Yang, Tzu-Ping Ko, Jiahn-Haur Liao, Nien-Tsung Lin, Chung-Yi Wu, Chien-Tai Ren, Andrew H.-J. Wang, Ching-Ming Chang, Kai-Fa Huang & Shih-Hsiung Wu. (2017) Structural basis for fragmenting the exopolysaccharide of Acinetobacter baumannii by bacteriophage ΦAB6 tailspike protein. Scientific Reports 7:1.
Crossref
Crossref
S. Jasemi, M. Douraghi, H. Adibhesami, H. Zeraati, M. Rahbar, M.A. Boroumand, A. Aliramezani, S. Ghourchian & M. Mohammadzadeh. (2016)
Trend of extensively drug-resistant
Acinetobacter baumannii
and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period
. Letters in Applied Microbiology 63:6, pages 466-472.
Crossref
Crossref
Seongman Bae, Min-Chul Kim, Su-Jin Park, Hee Sueng Kim, Heungsup Sung, Mi-Na Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Jun Hee Woo, Yang Soo Kim & Yong Pil Chong. (2016)
In Vitro
Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
. Antimicrobial Agents and Chemotherapy 60:11, pages 6774-6779.
Crossref
Crossref
Dong Liu, Zeng-Shan Liu, Pan Hu, Qi Hui, Bao-Quan Fu, Shi-Ying Lu, Yan-Song Li, De-Ying Zou, Zhao-Hui Li, Dong-Ming Yan, Yan-Xia Ding, Yuan-Yuan Zhang, Yu Zhou, Nan-Nan Liu & Hong-Lin Ren. (2016)
Characterization of a highly virulent and antimicrobial-resistant
Acinetobacter baumannii
strain isolated from diseased chicks in China
. Microbiology and Immunology 60:8, pages 533-539.
Crossref
Crossref
Jongsoo Jeon, Choong-Min Ryu, Jun-Young Lee, Jong-Hwan Park, Dongeun Yong & Kyungwon Lee. (2016)
In Vivo
Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357
. Applied and Environmental Microbiology 82:14, pages 4200-4208.
Crossref
Crossref
Bing Fan, Jie Guan, Xiumei Wang & Yulong Cong. (2016) Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. PLOS ONE 11:6, pages e0157757.
Crossref
Crossref
Elio Rossi, Francesca Longo, Marialuisa Barbagallo, Clelia Peano, Clarissa Consolandi, Alessandro Pietrelli, Sebastian Jaillon, Cecilia Garlanda & Paolo Landini. (2016)
Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen
Acinetobacter baumannii
. Future Microbiology 11:3, pages 335-349.
Crossref
Crossref
Şerife ALTUN, Zeliha KOÇAK TUFAN, Belgin ALTUN, Ufuk ÖNDE, Sami KINIKLI & Ali Pekcan DEMİRÖZ. (2016) Growing OXA-23 type strains among carbapenem-resistant Acinetobacter baumannii and tigecycline as an alternate combination therapy. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 1894-1899.
Crossref
Crossref
Alberto Oddo, Thomas T. Thomsen, Susanne Kjelstrup, Ciara Gorey, Henrik Franzyk, Niels Frimodt-Møller, Anders Løbner-Olesen & Paul R. Hansen. (2016)
An Amphipathic Undecapeptide with All
d
-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action
. Antimicrobial Agents and Chemotherapy 60:1, pages 592-599.
Crossref
Crossref
Yu-Shan Huang, Jann-Tay Wang, Wang-Huei Sheng, Yu-Chung Chuang & Shan-Chwen Chang. (2015) Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex. Journal of Microbiology, Immunology and Infection 48:5, pages 545-551.
Crossref
Crossref
Xavier Vila-Farrés, Rafael López-Rojas, Maria Eugenia Pachón-Ibáñez, Meritxell Teixidó, Jerónimo Pachón, Jordi Vila & Ernest Giralt. (2015) Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii. European Journal of Medicinal Chemistry 101, pages 34-40.
Crossref
Crossref
Qiang Fu, Huan Ye & Shumei Liu. (2015) Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii. American Journal of Infection Control 43:8, pages 857-860.
Crossref
Crossref
Younes Smani, Juan Domínguez-Herrera, José Ibáñez-Martínez & Jerónimo Pachón. (2015) Therapeutic Efficacy of Lysophosphatidylcholine in Severe Infections Caused by Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 59:7, pages 3920-3924.
Crossref
Crossref
Luis M. Jara, Pilar Cortés, Germán Bou, Jordi Barbé & Jesús Aranda. (2015) Differential Roles of Antimicrobials in the Acquisition of Drug Resistance through Activation of the SOS Response in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 59:7, pages 4318-4320.
Crossref
Crossref
Sergio Remolina, Gerson Arias & Ingrid Martínez. (2015) Neumonía adquirida en la comunidad polimicrobiana y multirresistente. Reporte de un caso. Acta Colombiana de Cuidado Intensivo 15:3, pages 234-240.
Crossref
Crossref
Yunsong Zhang, Tianhong Dai, Min Wang, Daniela Vecchio, Long Y Chiang & Michael R Hamblin. (2015)
Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide:
in vitro
and
in vivo
studies
. Nanomedicine 10:4, pages 603-614.
Crossref
Crossref
Yanping Luo, Gilman K. H. Siu, Amy S. F. Yeung, Jonathan H. K. Chen, Pak Leung Ho, K. W. Leung, Jacqueline L. Y. Tsang, Vincent C. C. Cheng, Ling Guo, Jiyong Yang, Liyan Ye & Wing-Cheong Yam. (2015) Performance of the VITEK MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid bacterial identification in two diagnostic centres in China. Journal of Medical Microbiology 64:1, pages 18-24.
Crossref
Crossref
Andrea Vergara, Yuliya Zboromyrska, Noraida Mosqueda, María Isabel Morosini, Sergio García-Fernández, Ignasi Roca, Rafael Cantón, Francesc Marco & Jordi Vila. (2014) Evaluation of a Loop-Mediated Isothermal Amplification-Based Methodology To Detect Carbapenemase Carriage in Acinetobacter Clinical Isolates. Antimicrobial Agents and Chemotherapy 58:12, pages 7538-7540.
Crossref
Crossref
Rocío Álvarez-Marín, José Molina Gil-Bermejo & José M. Cisneros. (2014) Epidemiology and Treatment of Multidrug-Resistant Acinetobacter baumannii. Current Treatment Options in Infectious Diseases 6:4, pages 409-424.
Crossref
Crossref
Magdalena Heindorf, Mahendar Kadari, Christine Heider, Evelyn Skiebe & Gottfried Wilharm. (2014) Impact of Acinetobacter baumannii Superoxide Dismutase on Motility, Virulence, Oxidative Stress Resistance and Susceptibility to Antibiotics. PLoS ONE 9:7, pages e101033.
Crossref
Crossref
Anna C. Jacobs, Mitchell G. Thompson, Chad C. Black, Jennifer L. Kessler, Lily P. Clark, Christin N. McQueary, Hanan Y. Gancz, Brendan W. Corey, Jay K. Moon, Yuanzheng Si, Matthew T. Owen, Justin D. Hallock, Yoon I. Kwak, Amy Summers, Charles Z. Li, David A. Rasko, William F. Penwell, Cary L. Honnold, Matthew C. Wise, Paige E. Waterman, Emil P. Lesho, Rena L. Stewart, Luis A. Actis, Thomas J. Palys, David W. Craft & Daniel V. Zurawski. (2014) AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments. mBio 5:3.
Crossref
Crossref
R. Manji, M. Bythrow, J. A. Branda, C.-A. D. Burnham, M. J. Ferraro, O. B. Garner, R. Jennemann, M. A. Lewinski, A. B. Mochon, G. W. Procop, S. S. Richter, J. A. Rychert, L. Sercia, L. F. Westblade & C. C. Ginocchio. (2013) Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. European Journal of Clinical Microbiology & Infectious Diseases 33:3, pages 337-346.
Crossref
Crossref
Nicola Petrosillo, Cecilia Melina Drapeau & Stefano Di Bella. 2014. Emerging Infectious Diseases. Emerging Infectious Diseases
255
272
.
Juliana Barin, Andreza Francisco Martins, Bianca Lucia Heineck, Afonso Luis Barth & Alexandre Prehn Zavascki. (2013) Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates. Annals of Clinical Microbiology and Antimicrobials 12:1.
Crossref
Crossref
L. Krizova, L. Poirel, P. Nordmann & A. Nemec. (2013) TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 68:12, pages 2786-2791.
Crossref
Crossref
Yuriko Fukuta, Robert R. Muder, Mounzer E. Agha, Lloyd G. Clarke, Marilyn M. Wagener, Amelia M. Hensler & Yohei Doi. (2013) Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. American Journal of Infection Control 41:12, pages 1249-1252.
Crossref
Crossref
Rafael López-Rojas, Michael J. McConnell, Manuel Enrique Jiménez-Mejías, Juan Domínguez-Herrera, Felipe Fernández-Cuenca & Jerónimo Pachón. (2013) Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness. Antimicrobial Agents and Chemotherapy 57:9, pages 4587-4589.
Crossref
Crossref
T. P. Gauthier. (2013) Editorial Commentary: Rifampicin Plus Colistin in the Era of Extensively Drug-Resistant Acinetobacter baumannii Infections. Clinical Infectious Diseases 57:3, pages 359-361.
Crossref
Crossref
Haiqing Chu, Lan Zhao, Minggui Wang, Yang Liu, Tao Gui & Jingbo Zhang. (2013) Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis. The Brazilian Journal of Infectious Diseases 17:4, pages 389-394.
Crossref
Crossref
María Carmen Fariñas & Luis Martínez-Martínez. (2013) Infecciones causadas por bacterias gramnegativas multirresistentes: enterobacterias, Pseudomonas aeruginosa, Acinetobacter baumannii y otros bacilos gramnegativos no fermentadores. Enfermedades Infecciosas y Microbiología Clínica 31:6, pages 402-409.
Crossref
Crossref
Ilias Karaiskos, Lambrini Galani, Fotini Baziaka, Emmanouela Katsouda, Ioannis Ioannidis, Alexandros Andreou, Harry Paskalis & Helen Giamarellou. (2013) Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. International Journal of Antimicrobial Agents 41:5, pages 480-483.
Crossref
Crossref
Salome N. Seiffert, Markus Hilty, Vincent Perreten & Andrea Endimiani. (2013) Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: An emerging problem for human health?. Drug Resistance Updates 16:1-2, pages 22-45.
Crossref
Crossref